The /3-lactamase stability and inhibitory activity of 1-oxa cephalosporin, (6R,7R)-7- [[carboxy(4-hydroxyphenyl)
The /3-lactamase stability and inhibitory activity of 1-oxa cephalosporin, (6R,7R)-7-[[carboxy(4-hydroxyphenyl)acetyl] amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio] methyl]-8-oxo-5-oxa-l-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, was investigated and compared to that of cefoxitin and cefotaxime. There was no detectable /8-lactamase hydrolysis of 1-oxa cephalosporin, cefotaxime and cefoxitin when incubated with fl-lactamases of plasmid or chromosomal origin which were primarily cephalosporinases or enzymes which hydrolyzed both penicillins and cephalosporins. The /3-lactamase inhibitory activity of 1-oxa cephalosporin was comparable to that of cefoxitin and cefotaxime. At equal molar concentration of substrate and inhibitor, cefoxitin, cefotaxime and 1-oxa cephalosporin effectively inhibited cephalosporinase hydrolysis of cephaloridine. Cefoxitin and cefotaxime were more effective inhibitors than the 1-oxa cephalosporin against a Providencia enzyme, whereas cefotaxime and 1-oxa cephalosporin were more effective inhibitors of a Citrobacter cephalosporinase.
The ability to produce /3-lactamases has been associated with the resistance of Gram-negative organisms to /3-lactam antibiotics4,7,9). Although /3-lactamases are not the only factors contributing to the resistance of Gram-negative bacteria to /3-lactam antibiotics, there is a growing interest in cephalosporins that are resistant to /3-lactamase hydrolysis. Recently we reported that a cephalosporin, cefotaxime, not only was resistant to /'-lactamase hydrolysis, but was also an effective cephalosporinase inhibitor3). The development of the 1-oxa cephalosporin, (6R,7R)-7-[[carboxy (4- 
.0]oct-2-ene-2-carboxylic acid, with the replacement of sulfur by oxygen at position one in the six membered dihydrothiazine component of the cephem nucleus prompted us to evaluate its /3-lactamase stability and its ability to inhibit /3-lactamases compared to cefoxitin and cefotaxime.
Materials and Methods
Organisms: All the organisms tested were clinical isolates from Columbia-Presbyterian Medical Center, New York City. The organisms were selected on the basis of their resistance to either cephaloridine or cephalothin and their production of /3-lactamase as determined by use of the chromogenic cephalosporin, nitrocefins6).
Antibiotics:
Cephaloridine, cephalothin and 1-oxa cephalosporin were gifts from Lilly Research Laboratories.
Cefoxitin was supplied by Merck Sharp & Dohme. Cefotaxime was obtained from Hoechst-Roussel. Antibacterial activity was determined by the agar dilution method in MUELLER-HINTON agar using an inoculum of 105 colony forming units (CFU)1). Synergy tests were determined by a checkerboard method described earlier1).
fl-Lactamase Preparation and Assay:
The /l-lactamases from Shigella sonnei 10-101, Pseudomonas aeruginosa 1882, Proteus morganii 771, Klebsiella pneumoniae 3971, Citrobacter freundii 2732, and P. aeruginosa 3901 have been described previously3). The Acinetobacter 4303 /3-lactamase was a constitutive enzyme. Providencia 3905 /3-lactamase was a constitutive enzyme and Providencia 2943 enzyme was induced by 25 ,rtg/ml cephaloridine by the method described earlier3). All enzymes were partially purified from sonic extracts which had been subjected to centrifugation and Sephadex G-50 column elution. Substrate specificity determination and inhibitor profile showed that the Providencia 2943 enzyme functioned primarily as a cephalosporinase; whereas the Providencia 3905 enzyme was a broad spectrum /3-lactamase hydrolyzing both penicillins and cephalosporins.
Assay of /3-Lactamase:
/3-Lactamase activity was determined by the spectrophotometric method in a temperature controlled spectrophotometer at 30°C2,3). The decrease in optical density at 255 nm was recorded for the first 5 minutes. Inhibition of the hydrolysis of cephaloridine was determined by the addition of cefoxitin, cefotaxime or 1-oxa cephalosporin. Kinetic parameters were estimated from a least squares fit to LINEWEAVER-BURK plots utilizing a computer program.
Results
The mean activity of the compound against fl-lactamase producing bacteria is given in Table 1 . The f3-lactamase stability of 1-oxa cephalosporin is presented in Table 2 . The 1-oxa cephalosporin was not hydrolyzed by any of the /3-lactamases, and had the same stability that cefoxitin and cefotaxime had. The stability of cefoxitin, cefotaxime and 1-oxa cephalosporin toward /3-lactamase hydrolysis prompted us to investigate their ability to inhibit the /3-lactamase hydrolysis of cephaloridine (Table  3) . At equimolar concentration of cephaloridine(0.2 mM), cefoxitin, cefotaxime and 1-oxa cephalosporin produced significant inhibition of the hydrolysis of cephaloridine by Citrobacter, Providencia 2943 and P. morganii /3-lactamases. On the other hand, no significant inhibitory activity was noted against the Shigella and Klebsiella enzymes. More than 70 % of the Acinetobacter 4303 /3-lactamase activity and 40% of Pseudomonas and Providencia 3905 enzyme activity were inhibited by the three antibiotics.
The comparative inhibitory activity of the compounds against a /3-lactamase with primary cephalo- Table 1 . Activity of 1-oxa cephalosporin against /3-lactamase producing bacteria. a The type of /3-lactamase is the same as in Table 1 . b Reaction mixture contains 0 .5 ml of 0.2 mM cephaloridine plus 0.5 ml of 0.05 M phosphate buffer (pH 7) as control or plus 0.5 ml of 0.2 mM of inhibitors. The hydrolysis of cephaloridine is given a value of 100.
sporinase activity was further investigated. Fig. 1 shows the inhibitory activity against /3-lactamase hydrolysis of cephaloridine at different concentrations of cefoxitin, cefotaxime and 1-oxa cephalosporin. Against the Providencia 2943 enzyme the inhibitory activity of cefoxitin was greater than that of cefotaxime and the 1-oxa cephalosporin. On the other hand, 1-oxa cephalosporin and cefotaxime were equivalent in inhibitory activity against the Citrobacter enzyme and ten-times more effective than was cefoxitin. The 1-oxa cephalosporin competitively inhibited both the Providencia (not shown) and Citrobacter enzyme hydrolysis of cephaloridine (Fig. 2) . For the Providencia enzyme, the 1-oxa cephalosporin had a Ki of 7.5 ,UM and a Km of 0.66 um. Against the Citrobacter enzyme the 1-oxa cephalosporin had Ki value of 2.27 x 10-2 itM and a Km value of 0.192 am. In contrast, cefoxitin tested with the Citrobacter enzyme had a Ki of 1.36pM and a Km of 0.244jtM, indicating cefoxitin was a less effective inhibitor. The Ki of dicloxacillin against this Citrobacter cephalosporinase was 1.6 x 10-3 ItM. The inhibition of cephaloridine hydrolysis by the 1-oxa cephalosporin suggested that it might act synergistically with other fl-lactam agents as do the /3-lactamase resistant penicillins. In order to determine if the inhibition found with the isolated enzymes was significant in intact growing cells, the compound was combined with cephaloridine and cephalothin and tested against selected /3-lactamase producing organisms in which the fl-lactamase had primarily cephalosporinase activity (Table  4) . Indifference and partial synergy was found when the compound was combined with cephaloridine and cephalothin against Pseudomonas, Acinetobacter, Klebsiella, Citrobacter, and Providencia. No antagonism was observed. However, the combination of 1-oxa cephalosporin with either cephalothin or cephaloridine showed a synergistic bactericidal inhibition of the Citrobacter freundii 2732 which produced a f3-lactamase that was inhibited by the 1-oxa cephalosporin (Fig. 3) . However, the low inhibitory level that the 1-oxa cephalosporin had against this organism would make this form of synergy unnecessary. Table 4 . Antibacterial activity of 1-oxa cephalosporin combined with cephaloridine and cephalothin. We have shown that cefoxitin, cefuroxime and cefotaxime not only are resistant to 8-lactamase hydrolysis, but also are inhibitors of /8-lactamases which are of chromosomal origin and act primarily as cephalosporinases3). This study demonstrates that the 1-oxa cephalosporin also is resistant to fl-lactamase hydrolysis and is a /3-lactamase inhibitor. The methoxy group in the 1-oxa cephalosporin may confer the resistance to /-lactamase hydrolysis as it does with cefoxitin.
The competitive nature of 1-oxa cephalosporin inhibition of certain fl-lactamases indicates that it competes with the substrate for the catalytic site in some /3-lactamases. However, the fact that like cefoxitin and cefotaxime, 1-oxa cephalosporin is not a substrate for other types of /3-lactamases and is not an inhibitor, suggests that it may not enter the catalytic site.
The inhibition of fl-lactamase which primarily have cephalosporinase activity would be of clinical importance. Organisms producing these type of /3-lactamases are major causes of serious Gram-negative infection in the hospital and are resistant to most penicillins and cephalosporins3). The recently developed /3-lactamase inhibitors, clavulanic acid and the penicillanic acid sulfone, do not inhibit these /3-lactamases2,5). Preliminary studies by our group indicate that this new compound does not induce /'-lactamases which hydrolyze other cephalosporins. Unfortunately, the combination of the 1-oxa cephalosporin with an agent such as cephaloridine, which readily enters many Gram-negative bacilli but is /3-lactamase unstable, did not result in synergy. It is possible that this is due to the greater affinity of the 1-oxa cephalosporin for /3-lactam receptor proteins in the intact organism than for the /-lactamase. Thus although this agent is almost as effective an inhibitor for certain /3-lactamases as are the /3-lactamase-resistant antistaphylococcal penicillins, the use of this compound with other /3-lactam compounds will not result in increased antibacterial activity.
